Trailer: Whistleblowing and Drug Safety Series - How Reprisals Occur

This is the third in the series of six policy briefs on whistleblowing and drug safety. Learn what happens to the whistleblower when she tries to do her job. And why she decided it was necessary to resign to warn Canadians about the harm that would occur. Read the Policy Brief on our website at www.whistleblowingcanada.com.
Update: A 2020 study confirms nifedipine capsule should not be used for cardiovascular disease, the very reason it was approved to be on the market since 1981.